IMMUNOHISTOCHEMICAL STUDY ON THE ROLE OF CD8+T LYMPHOCYTES IN THE PROGNOSIS OF INFILTRATING DUCTAL CARCINOMA BREAST
Main Article Content
Keywords
Breast carcinoma, CD8+T lymphocytes, immunosurviellance.
Abstract
Background: Breast carcinomas are often infiltrated by inflammatory cells, particularly T lymphocytes and macrophages, but significance of these cells remain unclear. One possible role of these inflammatory cells is that they produce a cell mediated immune response against the malignant cells. CD8+T lymphocytes are a known crucial component of cell mediated immunity. Cytotoxic CD8+T lymphocytes attach to tumor cells through major histocompatibility complex class-I on their surface. This leads to production of interferon gamma after interaction with tumor target and produces apoptosis, cell cycle inhibition, angiostasis and induction of macrophages which suppress the tumor growth.The accepted parameters for predicting the prognosis of breast carcinoma are grading and staging of tumor.
Objectives: To study the correlation between the CD8+ T lymphocyte density and histological grading of breast carcinoma. It also aims to compare the frequency of CD8+ T lymphocytes in breast carcinoma and benign proliferative breast lesions.
Method: Tissue blocks from 40 cases diagnosed as Invasive breast carcinoma NST(No special type) along with 20 benign proliferative breast lesions were included in the study. Histological grading was done based on Modified Bloom and Richardson grading system for invasive ductal carcinoma. All the 60 cases were immunostained with CD8 antibody and density of CD8+ T lymphocytes were semi-quantitatively graded according to Kreik et al[11].
Conclusion: Among the 40 cases of Invasive breast carcinoma NST, 90% cases showed CD8+T lymphocytes. 60% cases have moderate, 17.5% have minimal and 12.5% cases have extensive lymphocytic infiltrate. In the benign lesions, 50% cases showed the presence of CD8+T lymphocytic infiltrate, in which 30% showed minimal infiltrate and 20% showed moderate infiltrate. The densities of CD8+T lymphocytes were high in higher histological grades of the tumor. On comparing the density of lymphocytes with the stage of tumor, extensive infiltrates were noted in early stages of tumor and the distribution of these infiltrate were in peritumoral pattern.
References
2. World Health Organization. The Global Cancer Observatory: India Fact Sheet. Lyon: International Agency for Research on Cancer; 2021. Available from: https://gco.iarc.fr/today/data/factsheets/populations/356-india-fact-sheets.pdf
3. Newcomb PA, Trentham‐Dietz A, Hampton JM, et al. Late age at first full term birth is strongly associated with lobular breast cancer. Cancer 2011;117(9):1946-56.
4. Edge SB, Byrd DR, eds. AJCC cancer staging manual. 7th edn. New York: Springer 2010.
5. Pawelec G. Immunosenescence: impact in the young as well as the old?Mech Ageing Dev 1999;108:1-7.
6. Disis ML. Immune regulation of cancer. Journal of Clinical Oncology 2010;28(29):4531-8.
7. Smyth MJ, Dunn GP, Schreiber RD. Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumour development and shaping tumour immunogenicity. Adv Immunol 2006;90:1-50.
8. Shankaran V, Ikeda H, Bruce AT, et al. IFN-γ and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 2001;410(6832):1107-11.
9. Dunn GP, Old LJ, Schreiber RD. The three Es of cancer immunoediting. Annu Rev: Immunol2004:22:329-60.
10. Dennert G, Podack ER. Cytolysis by H-2 specific T killer cells. Assembly of tubular complexes on target membranes. J Exp Med 1983;157:1483-95.
11. Kreike B, van Kouwenhove M, Horlings H, et al. Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinoma. Breast Cancer Res 2007;9(5):R65.
12. HelalTE, Ibrahim EA, Alloub AI.Immunohistochemical analysis of tumour-infiltrating lymphocytes in breast carcinoma: relation to prognostic variables.Indian Journal of Pathology and Microbiology 2013;56(2):89-93.
13. An T, Sood U, Pietruk T, et al. In situ quantitation ofinflammatory mononuclear cells in ductal infiltratingbreast carcinoma. Am J Pathol 1987;128:52-60.
14. Ben-Hur H, Cohen O, Schneider D. The role of lymphocytes and macrophages in human breast tumorigenesis: An immunohistochemicaland morphometric study. Anticancer Res 2002;22:1231-8.
15. Mahmoud SM, Paish EC, Powe DG, et al. Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer. Journal of Clinical Oncology 2011;29(15):1949-55.
16. Rathore AS, Kumar S, Konwar R, et al. CD3+,CD4+&CD8+ tumour infiltrating (TILs) are predictors offavourable survival outcome in infiltrating ductal carcinoma of breast. Indian Journal ofMedical Research 2014;140(3):361-9.
17. Mor F, Quintana FJ, Cohen IR. Angiogenesis-inflammation cross-talk: vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization. The Journal of Immunology 2004;172(7):4618-23.
18. Gu X, Wang Y, Xiang J, et al. Interferon‐γ Triggers Hepatic Stellate Cell‐Mediated Immune Regulation through MEK/ERK Signaling Pathway. Journal of Immunology Research. 2013;2013(1):389807.
19. Gisterek I, Lata E, Halon A, et al. Prognostic role of c-met expression in breast cancer patients. Reports of Practical Oncology and Radiotherapy 2011;16(5):173-7.
20. Melichar B, Študentova H, Kalabova H, et al. Predictive and prognostic significance of tumor-infiltrating lymphocytes in patients with breast cancer treated with neoadjuvant systemic therapy. Anticancer Research 2014;34(3):1115-25.
21. Liu S, Lachapelle J, Leung S, et al. CD8+lymphocyte infiltration is an independent favourable prognostic indication in basal-like breast cancer. Breast Cancer Research 2012;14(2)212-7.